-78%

est. 2Y upside i

Series D+

Rank

#4299

Sector

Intelligent Document Processing (IDP)

Est. Liquidity

~3Y

Data Quality

Data: Medium

Hyperscience operates in a large, growing market with a differentiated product and strong gross margins.

Last updated: March 10, 2026

Bull (16%)+47%

The Hypercell platform achieves significant market penetration, leveraging its GenAI capabilities to capture substantial share from legacy IDP solutions and drive revenue to ~$67.5M by 2026. This strong performance, coupled with favorable market conditions, could justify a ~$2.4B valuation (35x revenue), providing a moderate return for common shareholders after accounting for liquidation preferences.

Base (44%)-37%

Hyperscience continues to grow at ~30-35% YoY, reaching ~$56M in revenue by 2026, but competitive pressures limit valuation multiples. An exit at ~$1.0B (18x revenue) would mean common shareholders receive significantly less than their pro-rata share, as the $439M in liquidation preferences would absorb a large portion of the exit value, resulting in a substantial loss from the Series E valuation.

Bear (40%)-70%

Intense competition from incumbents like Amazon Textract and UiPath leads to pricing pressure and slower growth, with revenue stalling at ~$40M by 2026. A down round or exit at ~$240M (6x revenue) would result in common stock being worth little to nothing, given the $439M in liquidation preferences that must be paid out first.

Est. time to liquidity~3.0 years

Preference Stack Risk

high

Investors hold $439M in liquidation preferences ahead of common shareholders, representing 27.26% of the current $1.61B valuation.

Dilution Risk

high

As a late-stage company with significant prior funding, future rounds or an IPO could lead to further dilution, especially if a new round is raised at a lower valuation than the Series E.

Secondary Liquidity

limited

While secondary markets exist for accredited investors, current market activity for Hyperscience shares is reported as low, with few buyers or sellers.

Sales — 1 role

View all 1 open roles at Hyperscience →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Hyperscience's data — designed to show you've done your homework.

  • 1

    “Given the strong competition from large players like Amazon Textract and UiPath's Document Understanding, how does Hyperscience plan to maintain its competitive moat and pricing power, especially as GenAI capabilities become more commoditized?”

  • 2

    “With the Series E valuation at $1.61B and reported revenue around $30M, how does the company view its current valuation relative to its growth trajectory, and what is the strategy to achieve a valuation that provides meaningful returns for common shareholders, especially considering the $439M in liquidation preferences?”

  • 3

    “The company has achieved FedRAMP High Authorization and has notable government customers. What is the strategy for expanding further into the public sector, and how does this regulatory barrier provide a sustainable competitive advantage?”

Community

Valuation Sentiment

Our model estimates -78% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.